133 related articles for article (PubMed ID: 35795207)
1. Case Report: A Chinese Family of Hypertrophic Cardiomyopathy Caused by a Novel Splicing Mutation in the
Huang C; Zheng Y; Zhang W; Chen Z; Huang Z; Fang Y
Front Genet; 2022; 13():894791. PubMed ID: 35795207
[TBL] [Abstract][Full Text] [Related]
2. Case Report: Novel Likely Pathogenic
Park J; Cho YG; Park HW; Cho JS
Front Pediatr; 2021; 9():609389. PubMed ID: 33859969
[TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing reveals MYH7 p.R671C mutation in three different phenotypes of familial hypertrophic cardiomyopathy.
Yu W; Huang MM; Zhang GH; Wang W; Chen CJ; Cheng JD
Exp Ther Med; 2021 Sep; 22(3):1002. PubMed ID: 34345284
[TBL] [Abstract][Full Text] [Related]
4. A Novel
Peng Y; Xu J; Wang Y; Zhao J; Zhang L; Chen Z; Jiang Y; Banerjee S; Zhang Z; Bai M
Balkan J Med Genet; 2022 Jun; 25(1):71-78. PubMed ID: 36880031
[TBL] [Abstract][Full Text] [Related]
5. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Diversity of Cardiomyopathy Caused by an
Park J; Lee JM; Cho JS
Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803538
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing (NGS) as a molecular diagnostic tool for hypertrophic cardiomyopathy in a Chinese boy due to novel compound heterozygous mutations in the MYBPC3 gene: A case report.
Chen X; Jiang J; Zhu W; Wu Y; Su M
Medicine (Baltimore); 2019 Mar; 98(12):e14676. PubMed ID: 30896616
[TBL] [Abstract][Full Text] [Related]
8. Novel filamin C (FLNC) variant causes a severe form of familial mixed hypertrophic-restrictive cardiomyopathy.
Gaudreault N; Ruel LJ; Henry C; Schleit J; Lagüe P; Champagne J; Sénéchal M; Sarrazin JF; Philippon F; Bossé Y; Steinberg C
Am J Med Genet A; 2023 Jun; 191(6):1508-1517. PubMed ID: 36864778
[TBL] [Abstract][Full Text] [Related]
9. Mutation profile of FLNC gene and its prognostic relevance in patients with hypertrophic cardiomyopathy.
Cui H; Wang J; Zhang C; Wu G; Zhu C; Tang B; Zou Y; Huang X; Hui R; Song L; Wang S
Mol Genet Genomic Med; 2018 Nov; 6(6):1104-1113. PubMed ID: 30411535
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
[TBL] [Abstract][Full Text] [Related]
11. Screening of the
Gómez J; Lorca R; Reguero JR; Morís C; Martín M; Tranche S; Alonso B; Iglesias S; Alvarez V; Díaz-Molina B; Avanzas P; Coto E
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28356264
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
[TBL] [Abstract][Full Text] [Related]
13. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Novel LIM domain-binding protein 3 (LDB3) mutations associated with hypertrophic cardiomyopathy family.
Zheng J; Huang Z; Hou S; Jiang X; Zhang Y; Liu W; Jia J; Li Y; Sun X; Xie L; Zhao X; Hou C; Xiao T
Front Pediatr; 2022; 10():947963. PubMed ID: 36452351
[TBL] [Abstract][Full Text] [Related]
15. A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.
Huang X; Song L; Ma AQ; Gao J; Zheng W; Zhou X; Zhang Q; Lu H; Li Y; Liu Y; Hui R
Clin Chim Acta; 2001 Aug; 310(2):131-9. PubMed ID: 11498078
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing identified a novel heterozygous mutation of SALL1 and a new homozygous mutation of PTPRQ in a Chinese family with Townes-Brocks syndrome and hearing loss.
Yang G; Yin Y; Tan Z; Liu J; Deng X; Yang Y
BMC Med Genomics; 2021 Jan; 14(1):24. PubMed ID: 33478437
[TBL] [Abstract][Full Text] [Related]
17. Identification of three novel pathogenic mutations in sarcomere genes associated with familial hypertrophic cardiomyopathy based on multi-omics study.
Liu W; Wei Z; Zhang Y; Liu Y; Bai R; Ma C; Yang J; Sun D
Clin Chim Acta; 2021 Sep; 520():43-52. PubMed ID: 34087240
[TBL] [Abstract][Full Text] [Related]
18. Serial observations and mutational analysis of an adoptee with family history of hypertrophic cardiomyopathy.
Harris B; Pfotenhauer JP; Silverstein CA; Markham LW; Schafer K; Exil VJ; Hong CC
Cardiol Res Pract; 2010; 2010():697269. PubMed ID: 20309391
[TBL] [Abstract][Full Text] [Related]
19. A novel compound heterozygous variant in
Li T; Jin Y; Liu R; Hua Y; Zhou K; Luo S; Li Y; Zhang D
Front Cardiovasc Med; 2023; 10():1212417. PubMed ID: 37396576
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome DNA sequencing: The key to detecting a sarcomeric mutation in a 'false genotype-negative' family with hypertrophic cardiomyopathy.
Gomes AC; Barbosa PS; Coutinho A; Cruz I; Carmo-Fonseca M; Lopes LR
Rev Port Cardiol (Engl Ed); 2020 Apr; 39(4):227.e1-227.e9. PubMed ID: 32451163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
